TY - JOUR
T1 - Do multiple types of confirmatory tests improve performance in predicting subtypes of primary aldosteronism?
AU - Kaneko, Hiroki
AU - Umakoshi, Hironobu
AU - Fukumoto, Tazuru
AU - Wada, Norio
AU - Ichijo, Takamasa
AU - Sakamoto, Shohei
AU - Watanabe, Tetsuhiro
AU - Ishihara, Yuki
AU - Tagami, Tetsuya
AU - Ogata, Masatoshi
AU - Iwahashi, Norifusa
AU - Yokomoto-Umakoshi, Maki
AU - Matsuda, Yayoi
AU - Sakamoto, Ryuichi
AU - Ogawa, Yoshihiro
N1 - Funding Information:
This work was supported in part by the grants from JSPS KAKENHI (JP22K08627 to H. U., JP20K16525 and JP21J40043 to M. Y‐U. and JP22H4993 to Y. O.), the Takeda Science Foundation (H. U.), the Uehara Memorial Foundation (H. U.), the Japan Foundation for Applied Enzymology (H. U. and M. Y‐U.) and the Secom Science and Technology Foundation (Y. O.).
Publisher Copyright:
© 2022 John Wiley & Sons Ltd.
PY - 2022
Y1 - 2022
N2 - Objective: The clinical practice guideline for primary aldosteronism (PA) places a high value on confirmatory tests to sparing patients with false-positive results in case detection from undergoing adrenal venous sampling (AVS). However, it is unclear whether multiple types of confirmatory tests are more useful than a single type. To evaluate whether the machine-learned combination of two confirmatory tests is more useful in predicting subtypes of PA than each test alone. Design: A retrospective cross-sectional study in referral centres. Patients: This study included 615 patients with PA randomly assigned to the training and test data sets. The participants underwent saline infusion test (SIT) and captopril challenge test (CCT) and were subtyped by AVS (unilateral, n = 99; bilateral, n = 516). Measurements: The area under the curve (AUC) and clinical usefulness using decision curve analysis for the subtype prediction in the test data set. Results: The AUCs for the combination of SIT and CCT, SIT alone and CCT alone were 0.850, 0.813 and 0.786, respectively, with no significant differences between them. The AUC for the baseline clinical characteristics alone was 0.872, whereas the AUCs for these combined with SIT, combined with CCT and combined with both SIT and CCT were 0.868, 0.854 and 0.855, respectively, with no significant improvement in AUC. The additional clinical usefulness of the second confirmatory test was unremarkable on decision curve analysis. Conclusions: Our data suggest that patients with positive case detection undergo one confirmatory test to determine the indication for AVS.
AB - Objective: The clinical practice guideline for primary aldosteronism (PA) places a high value on confirmatory tests to sparing patients with false-positive results in case detection from undergoing adrenal venous sampling (AVS). However, it is unclear whether multiple types of confirmatory tests are more useful than a single type. To evaluate whether the machine-learned combination of two confirmatory tests is more useful in predicting subtypes of PA than each test alone. Design: A retrospective cross-sectional study in referral centres. Patients: This study included 615 patients with PA randomly assigned to the training and test data sets. The participants underwent saline infusion test (SIT) and captopril challenge test (CCT) and were subtyped by AVS (unilateral, n = 99; bilateral, n = 516). Measurements: The area under the curve (AUC) and clinical usefulness using decision curve analysis for the subtype prediction in the test data set. Results: The AUCs for the combination of SIT and CCT, SIT alone and CCT alone were 0.850, 0.813 and 0.786, respectively, with no significant differences between them. The AUC for the baseline clinical characteristics alone was 0.872, whereas the AUCs for these combined with SIT, combined with CCT and combined with both SIT and CCT were 0.868, 0.854 and 0.855, respectively, with no significant improvement in AUC. The additional clinical usefulness of the second confirmatory test was unremarkable on decision curve analysis. Conclusions: Our data suggest that patients with positive case detection undergo one confirmatory test to determine the indication for AVS.
UR - http://www.scopus.com/inward/record.url?scp=85143423174&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85143423174&partnerID=8YFLogxK
U2 - 10.1111/cen.14854
DO - 10.1111/cen.14854
M3 - Article
C2 - 36415024
AN - SCOPUS:85143423174
SN - 0300-0664
JO - Clinical Endocrinology
JF - Clinical Endocrinology
ER -